SERIES [A][B] COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • November 12th, 2019 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
Contract Type FiledNovember 12th, 2019 Company Industry JurisdictionTHIS SERIES [A][B] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, CEDE & CO. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Authorized Share Increase Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______ 1 2 . (the “Termination Date”) but not thereafter, to subscribe for and purchase from Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this W
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 2nd, 2023 • Yield10 Bioscience, Inc. • Agricultural production-crops • New York
Contract Type FiledAugust 2nd, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August [ ], 2023 between Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.3.3 NON-QUALIFIED STOCK OPTION AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER THE METABOLIX, INC. 2006 STOCK OPTION AND INCENTIVE PLANNon-Qualified Stock Option Agreement • October 20th, 2006 • Metabolix, Inc. • Miscellaneous plastics products
Contract Type FiledOctober 20th, 2006 Company Industry
OFOperating Agreement • October 20th, 2006 • Metabolix, Inc. • Miscellaneous plastics products • Delaware
Contract Type FiledOctober 20th, 2006 Company Industry Jurisdiction
ARTICLE IStockholders' Agreement • August 31st, 2006 • Metabolix, Inc. • Miscellaneous plastics products • Massachusetts
Contract Type FiledAugust 31st, 2006 Company Industry Jurisdiction
WHENEVER CONFIDENTIAL INFORMATION IS OMITTED HEREIN (SUCH OMISSIONS ARE DENOTED BY AN ASTERISK*), SUCH CONFIDENTIAL INFORMATION HAS BEEN SUBMITTED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT....License Agreement • October 20th, 2006 • Metabolix, Inc. • Miscellaneous plastics products • Massachusetts
Contract Type FiledOctober 20th, 2006 Company Industry Jurisdiction
METABOLIX, INC.Incentive Stock Option Agreement • August 31st, 2006 • Metabolix, Inc. • Miscellaneous plastics products • Delaware
Contract Type FiledAugust 31st, 2006 Company Industry Jurisdiction
METABOLIX, INC.Common Stock Purchase Warrant • August 31st, 2006 • Metabolix, Inc. • Miscellaneous plastics products • Massachusetts
Contract Type FiledAugust 31st, 2006 Company Industry Jurisdiction
Exhibit 10.14 INDEMNIFICATION AGREEMENT This Agreement made and entered into this ____ day of ______, 2006 (the "AGREEMENT"), by and between Metabolix, Inc., a Delaware corporation (the "COMPANY," which term shall include, where appropriate, any...Indemnification Agreement • October 20th, 2006 • Metabolix, Inc. • Miscellaneous plastics products • Delaware
Contract Type FiledOctober 20th, 2006 Company Industry Jurisdiction
COMMON STOCKPurchase Agreement • November 6th, 2006 • Metabolix, Inc. • Miscellaneous plastics products • New York
Contract Type FiledNovember 6th, 2006 Company Industry Jurisdiction
METABOLIX, INC. 6,200,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • May 19th, 2011 • Metabolix, Inc. • Miscellaneous plastics products • New York
Contract Type FiledMay 19th, 2011 Company Industry JurisdictionMetabolix, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC is acting as the sole representative (the “Representative”), an aggregate of 6,200,000 shares of common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 930,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares include 2,278,500 shares of common stock, par value $0.01 per share, of the company (the “Other Underwritten Shares”) to be purchased by an existing stockholder of the Company who is an affiliate of a director of the Company and certain other directors and officers of the Company (the “Other Underwritten Share Purchasers”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstand
AMENDMENT NO. 1 TO FIFTH AMENDED AND RESTATED STOCKHOLDERS' AGREEMENTStockholders' Agreement • July 14th, 2006 • Metabolix Inc
Contract Type FiledJuly 14th, 2006 Company
UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2009 • Metabolix, Inc. • Miscellaneous plastics products • New York
Contract Type FiledNovember 12th, 2009 Company Industry Jurisdiction
PAGE ARTICLE 1: BASIC TERMS...........................................................1 ARTICLE 2: PREMISES AND APPURTENANT RIGHTS.......................................6 2.01 Lease of Premises; Appurtenant Rights....................................6...Lease Agreement • August 31st, 2006 • Metabolix, Inc. • Miscellaneous plastics products • Massachusetts
Contract Type FiledAugust 31st, 2006 Company Industry Jurisdiction
FORM OF COMMON STOCK PURCHASE WARRANT YIELD10 BIOSCIENCE, INC.Common Stock Purchase Warrant • May 4th, 2023 • Yield10 Bioscience, Inc. • Agricultural production-crops
Contract Type FiledMay 4th, 2023 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six month anniversary of the Issue Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from YIELD10 BIOSCIENCE, INC., a Delaware corporation (the “Company”), up to [ · ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
METOBOLIX LOGO] 21 Erie Street WHERE NATURE PERFORMS(TM) Cambridge, Massachusetts 02139-4260 USA Tel: 617.492.0505 - Fax: 617-492-1996 Web: www.metabolix.com September 18, 2006Employment Agreement • October 20th, 2006 • Metabolix, Inc. • Miscellaneous plastics products • Massachusetts
Contract Type FiledOctober 20th, 2006 Company Industry Jurisdiction
UNDER THE METABOLIX, INC. 2006 STOCK OPTION AND INCENTIVE PLAN Name of Optionee: No. of Option Shares: Option Exercise Price per Share: $ [FMV ON GRANT DATE] Grant Date: Expiration Date:Non-Qualified Stock Option Agreement • October 20th, 2006 • Metabolix, Inc. • Miscellaneous plastics products
Contract Type FiledOctober 20th, 2006 Company Industry
WITNESSETHLicense Agreement • August 31st, 2006 • Metabolix, Inc. • Miscellaneous plastics products • Massachusetts
Contract Type FiledAugust 31st, 2006 Company Industry Jurisdiction
YIELD10 BIOSCIENCE, INC. and EQUINITI TRUST COMPANY, LLC, as Warrant Agent Warrant Agency Agreement Dated as of August __, 2023 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • August 2nd, 2023 • Yield10 Bioscience, Inc. • Agricultural production-crops • New York
Contract Type FiledAugust 2nd, 2023 Company Industry JurisdictionWARRANT AGENCY AGREEMENT, dated as of August ___, 2023 (“Agreement”), between Yield10 Bioscience, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and Equiniti Trust Company, LLC (the “Warrant Agent”).
12,480,000 SHARES OF COMMON STOCK, 2,504 SHARES OF SERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO 12,520,000 SHARES OF COMMON STOCK), WARRANTS EXERCISABLE INTO 50,000,000 SHARES OF COMMON STOCK OF YIELD10 BIOSCIENCE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 20th, 2019 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
Contract Type FiledNovember 20th, 2019 Company Industry JurisdictionThe undersigned, Yield10 Bioscience, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Yield10 Bioscience, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
COMMON STOCK PURCHASE WARRANT YIELD10 BIOSCIENCE, INC.Security Agreement • July 5th, 2017 • Yield10 Bioscience, Inc. • Miscellaneous plastics products
Contract Type FiledJuly 5th, 2017 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 7, 2018 (the “Initial Exercise Date”) and on or prior to the close of business on the six (6) year anniversary of the Initial Exercise Date (the “Termination Date”; provided, however that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day) but not thereafter, to subscribe for and purchase from Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 5th, 2017 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
Contract Type FiledJuly 5th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 3, 2017, between Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
METABOLIX LOGO] 21 Erie Street WHERE NATURE PERFORMS(TM) Cambridge, Massachusetts 02139-4260 USA Tel: 617.492.0505 - Fax: 617-492-1996 Web: www.metabolix.com September 18, 2006Employment Agreement • October 20th, 2006 • Metabolix, Inc. • Miscellaneous plastics products • Massachusetts
Contract Type FiledOctober 20th, 2006 Company Industry Jurisdiction
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • October 7th, 2015 • Metabolix, Inc. • Miscellaneous plastics products • Illinois
Contract Type FiledOctober 7th, 2015 Company Industry JurisdictionCOMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of October 7, 2015, by and between METABOLIX, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
SHARES OF COMMON STOCK, _____ SHARES OF SERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO _______ SHARES OF COMMON STOCK), WARRANTS EXERCISABLE INTO _______ SHARES OF COMMON STOCK OF YIELD10 BIOSCIENCE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 11th, 2019 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
Contract Type FiledOctober 11th, 2019 Company Industry Jurisdiction
EXHIBIT 10.3.1 INCENTIVE STOCK OPTION AGREEMENT UNDER THE METABOLIX, INC. 2006 STOCK OPTION AND INCENTIVE PLAN Name of Optionee: No. of Option Shares: Option Exercise Price per Share: $ [FMV ON GRANT DATE (110% OF FMV IF A 10% OWNER)] Grant Date:...Incentive Stock Option Agreement • October 20th, 2006 • Metabolix, Inc. • Miscellaneous plastics products
Contract Type FiledOctober 20th, 2006 Company Industry
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 7th, 2015 • Metabolix, Inc. • Miscellaneous plastics products • Illinois
Contract Type FiledOctober 7th, 2015 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 7, 2015, by and between METABOLIX, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
YIELD10 BIOSCIENCE, INC. Up to $4,200,000 of Common Stock EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • January 24th, 2023 • Yield10 Bioscience, Inc. • Agricultural production-crops • New York
Contract Type FiledJanuary 24th, 2023 Company Industry JurisdictionYield10 Bioscience, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, common stock of the Company, par value $0.01 per share (the “Common Stock”), having an aggregate offering price of up to $4,200,000 of Common Stock (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Common Stock to be issued and sold by the Company.
SERIES A WARRANTS EXERCISABLE INTO SHARES OF COMMON STOCK AND SERIES B WARRANTS EXERCISABLE INTO SHARES OF COMMON STOCK OF YIELD10 BIOSCIENCE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 15th, 2017 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
Contract Type FiledDecember 15th, 2017 Company Industry JurisdictionThe undersigned, Yield10 Bioscience, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Yield10 Bioscience, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
LEASE AGREEMENTLease Agreement • January 26th, 2016 • Metabolix, Inc. • Miscellaneous plastics products
Contract Type FiledJanuary 26th, 2016 Company IndustryTHIS LEASE AGREEMENT (this “Lease”) is made this 20th day of January, 2016, between ARE-MA REGION NO. 20, LLC, a Delaware limited liability company (“Landlord”), and METABOLIX, INC., a Delaware corporation (“Tenant”).
YIELD10 BIOSCIENCE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2021 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
Contract Type FiledFebruary 2nd, 2021 Company Industry JurisdictionYield10 Bioscience, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of 1,040,000 shares (“Firm Shares”, or “Securities”) of the Company’s common stock, $0.01 par value per share (“Shares”) to the several underwriters (such underwriters, for whom Maxim Group LLC (“Maxim” or the “Representative”) is acting as representative, the “Underwriters” and each an “Underwriter”). The offering of the Securities is hereinafter called the “Offering”.
EXHIBIT 10.18 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT is entered into as of July 12, 2006, by and among Metabolix, Inc., a Delaware corporation (the "COMPANY"), and Archer-Daniels-Midland Company, a Delaware corporation ("INVESTOR")....Stock Purchase Agreement • July 14th, 2006 • Metabolix Inc • Massachusetts
Contract Type FiledJuly 14th, 2006 Company Jurisdiction
YIELD10 BIOSCIENCE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 25th, 2020 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
Contract Type FiledAugust 25th, 2020 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 4th, 2023 • Yield10 Bioscience, Inc. • Agricultural production-crops • New York
Contract Type FiledMay 4th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 3, 2023 between Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT yield10 bioscience, inc.Common Stock Agreement • March 22nd, 2024 • Yield10 Bioscience, Inc. • Agricultural production-crops
Contract Type FiledMarch 22nd, 2024 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Shareholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).